Adlai Nortye Group Ltd. cash flow statement
In fiscal 2025, Adlai Nortye Group Ltd.'s operations generated −$33.5m of cash; it spent $187,000 on capital projects, leaving free cash flow of −$33.6m.
Cash flow statement
Compare with peers
- Inventiva S.a. cash flow
- Rani Therapeutics Holdings, Inc. cash flow
- Immuron Ltd cash flow
- Bolt Biotherapeutics, Inc. cash flow
- Entrada Therapeutics, Inc. cash flow
Head to head: ANL vs IVAANL vs RANIANL vs IMRN
More: Biotechnology stocks compared, Health Care sector, rankings of US companies